IDENTIFICATION AND CHARACTERIZATION OF NOVEL TARGETABLE MECHANISMS ASSOCIATED WITH HOMOLOGOUS RECOMBINATION REPAIR DEFECTS IN MCRPC PATIENTS...CORRECTED ENTRY FROM 7/30/2019 AS FORMULA GRANT
$1,076,301FY2019Department of the ArmyDOD
Sloan-Kettering Institute For Cancer Research